Supernus Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
Abbott USD 25.12B 28M 2025-03
ANI Pharmaceuticals USD 2K 0 2025-03
Aurora Cannabis CAD 6.98B 907K 2024-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 105.29M 105.15M 2025-06
Eisai JPY 282.12M 44.7B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Novo Nordisk 4.44B 3.99B 2025-06
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 6.56B 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Supernus Pharmaceuticals USD 56.12M 130K 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06
Xeris Pharmaceuticals USD 15K 0 2024-12


Supernus Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.